Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology IV1 Apr 2018PD65-10 PRLZ INCREASES PROSTATE CANCER DOCETAXEL RESISTANCE BY INHIBITING LKB1/AMPK-MEDIATED AUTOPHAGY Jin Zeng, Wei Liu, Yizeng Fan, Dalin He, and Lei Li Jin ZengJin Zeng More articles by this author , Wei LiuWei Liu More articles by this author , Yizeng FanYizeng Fan More articles by this author , Dalin HeDalin He More articles by this author , and Lei LiLei Li More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2994AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Docetaxel-mediated chemotherapy is the first-line standard approach and has been determined to show a survival advantage for metastatic castration-resistant prostate cancer (mCRPC) patients. However, a substantial proportion of patients eventually becomes refractory due to drug resistance. The detailed mechanisms remain unclear. We have previously reported that Prostate Leucine Zipper (PrLZ), a specific oncogene of prostate cancer (PCa), promotes PCa cell growth at the castration-resistant stage, thus suggesting a vital role of PrLZ in the progression of CRPC. In this study, we aimed to investigate the role of PrLZ in docetaxel resistance in PCa, focusing on PrLZ-regulating autophagy pathway. METHODS Human PCa PC3, LNCaP and C4-2 cell lines were used as the model system in vitro and PCa xenografts and PrLZ-knockout mice were used as the model system in vivo. Docetaxel-induced cell death and apoptosis in PCa were determined by MTT and flow cytometry assay. The effects of PrLZ on autophagy were determined by LC3 conversion, LC3 turnover, and LC3-GFP-RFP puncta assay. The role of PrLZ in the regulation of autophagy and liver kinase B1/AMP-activated protein kinase (LKB1/AMPK) signaling pathway was analyzed using immunoblotting, immunoprecipitation, siRNA silencing and plasmid overexpression. RESULTS PrLZ increased docetaxel-mediated drug resistance in PCa both in vitro and in vivo. PrLZ was involved in both glucose starvation and docetaxel-induced autophagy. Mechanistic dissection revealed that PrLZ interacted with LKB1 and further inhibited the activation of LKB1/AMPK signals, which negatively contributed to the induction of autophagy. Moreover, PrLZ/LKB1-mediated autophagy conferred resistance to docetaxel-induced cell death and apoptosis both in vitro and in vivo. CONCLUSIONS These findings identify a novel role of PrLZ in autophagy manipulation and provide new insight into docetaxel chemoresistance in PCa, suggesting a new strategy for treating mCRPC by targeting this newly identified signaling pathway. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e1228-e1229 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Jin Zeng More articles by this author Wei Liu More articles by this author Yizeng Fan More articles by this author Dalin He More articles by this author Lei Li More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death.

Testicular Orphan Nuclear Receptor 4 is Associated with the Radio-Sensitivity of Prostate Cancer.

Nkx3.1 and P27kip1cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells

Inhibition of Both EGFR and IGF1R Sensitized Prostate Cancer Cells to Radiation by Synergistic Suppression of DNA Homologous Recombination Repair

PC-1/PrLZ Confers Resistance to Rapamycin in Prostate Cancer Cells Through Increased 4E-BP1 Stability.

Targeting proliferating cell nuclear antigen enhances ionizing radiation‐induced cytotoxicity in prostate cancer cells

Inhibition of PCSK9 Protects Against Radiation-Induced Damage of Prostate Cancer Cells.

PC-1/PrLZ Contributes to Malignant Progression in Prostate Cancer.

Additive Effects of a Small Molecular PCNA Inhibitor PCNA-I1S and DNA Damaging Agents on Growth Inhibition and DNA Damage in Prostate and Lung Cancer Cells

PrLZ Increases Prostate Cancer Docetaxel Resistance by Inhibiting LKB1/AMPK-mediated Autophagy.

Enhanced Autophagy Promotes Radiosensitivity by Mediating Sirt1 Downregulation in RM-1 Prostate Cancer Cells.

Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer.

Cabazitaxel Suppresses the Proliferation and Promotes the Apoptosis and Radiosensitivity of Castration-Resistant Prostate Cancer Cells by Inhibiting PI3K/AKT Pathway.

HZ08 Suppresses RelB-activated MnSOD Expression and Enhances Radiosensitivity of Prostate Cancer Cells

Suppression of Bcl-xL Expression by a Novel Tumor-Specific RNA Interference System Inhibits Proliferation and Enhances Radiosensitivity in Prostatic Carcinoma Cells

PD65-10 PRLZ INCREASES PROSTATE CANCER DOCETAXEL RESISTANCE BY INHIBITING LKB1/AMPK-MEDIATED AUTOPHAGY

Inhibition Of Ezh2 By Chemo- And Radiotherapy Agents And Small Molecule Inhibitors Induces Cell Death In Castration-Resistant Prostate Cancer

Chk 1 Knockdown Confers Radiosensitization in Prostate Cancer Stem Cells

Transcription Factor HBP1 Enhances Radiosensitivity by Inducing Apoptosis in Prostate Cancer Cell Lines

Increased Prlz-Mediated Androgen Receptor Transactivation Promotes Prostate Cancer Growth At Castration-Resistant Stage

LINC00861 Promotes Immune Response in the Tumor Microenvironment and Inhibits Prostate Cancer Tumor Growth by Regulating PD-L1